How Much Is SIA "Intramed Imaging" (IMI) Worth?
SIA "Intramed Imaging" (IMI) - Company Valuation
Combines filings, registry risk signals, and versioned market evidence. Learn More ↗ Opens in a New Tab
Enterprise Value
307,575 €
- Range
- 214,597 €–551,744 €
- Evidence StrengthShows how strongly available evidence supports the result. Learn More ↗ Opens in a New Tab
- Low
- Based on FY
- 2025
- Valuation Date
- Business StrengthSummarises business strength from financial and public-record signals. Learn More ↗ Opens in a New Tab
- B+
- Altman Z″Indicates financial-distress risk. A higher score is stronger. Learn More ↗ Opens in a New Tab
- 22.24
- Risks
- Insufficient Data
Scope & Evidence
- Company
- SIA "Intramed Imaging" (IMI)
- Registration
- LV · 50003608821
- Covers
- Single Company
- Filings Used
- 12 · FY 2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014
Industry: NACE 86 · 1 Emerging Markets industry cohort
Methodology & Assumptions
- Industry EV / EBITDA
- 19.0×
- Industry Revenue Multiple
- 3.65×
- Revenue Multiple
- 3.65×
- Enterprise Value
- 307,575 €
- Value Before Discount
- 307,575 €
Key Ratios
- Current RatioCurrent assets divided by current liabilities. Learn More ↗ Opens in a New Tab
- 9.77×
- Quick RatioCurrent assets minus inventory, divided by current liabilities. Learn More ↗ Opens in a New Tab
- 9.77×
- Debt / EquityTotal liabilities divided by equity. Learn More ↗ Opens in a New Tab
- 0.09×
- Equity RatioEquity as a share of total assets. Learn More ↗ Opens in a New Tab
- 91.3%
- Interest CoverageEBIT divided by interest expense. Learn More ↗ Opens in a New Tab
- ≥ 100.00×
- Gross MarginGross profit as a share of revenue. Learn More ↗ Opens in a New Tab
- 52.6%
- Net Profit MarginNet profit as a share of revenue. Learn More ↗ Opens in a New Tab
- 17.2%
- Return on EquityNet profit as a share of owners' equity. Learn More ↗ Opens in a New Tab
- 48.4%
- Return on AssetsNet profit as a share of total assets. Learn More ↗ Opens in a New Tab
- 44.2%
- Revenue CAGRAverage annual revenue growth over the available period. Learn More ↗ Opens in a New Tab
- 5.1%
Asset Distribution
Fixed AssetsCashReceivables
Liability Maturity
Short-Term
3-Year Revenue Scenarios
120k €
90k €
60k €
30k €
0 €
202620272028
OptimisticBaseConservative
A comparison between a company and a defined peer group. Learn More ↗ Opens in a New Tab
Revenue vs Industry Peers
- SIA "FLEBOMEDIKA"
- 9,643,364 €
- SIA "iVF Riga"
- 7,084,313 €
- SIA "Intramed Imaging" (IMI) ★
- 86,191 €
- SIA "SURDOVEST"
- 59,958 €
- Sabiedrība ar ierobežotu atbildību "Homeopātijas un akupunktūras centrs"
- 37,740 €
- Sabiedrība ar ierobežotu atbildību "Juveks un Ko"
- 33,117 €
- Sabiedrība ar ierobežotu atbildību "NeuroPhys"
- 12,495 €
Earnings before interest, taxes, depreciation, and amortisation. Learn More ↗ Opens in a New Tab
Revenue, Profit & EBITDA
100k €
75k €
50k €
25k €
0 €
20212022202320242025
RevenueNet Profit
Versus Industry Median
100k €
75k €
50k €
25k €
0 €
RevenueNet Profit
This CompanyIndustry Median